Tilray Inc (NASDAQ:TLRY) Ventures Into Ireland’s Medical Cannabis Market With GMP-Certified Cannabis Oils

Tilray Inc (NASDAQ:TLRY) recently announced that it added Ireland the list of markets where it sells its cannabis products, particularly its Good Manufacturing Practices (GMP)-certified medical marijuana oils.

The company announced on Friday last week that it imported its GMP-certified cannabis oils into the Ireland where they will be made available throughout the European country. Tilray’s expansion into the country is also courtesy of the Medical Cannabis Access Programme which was enacted by Ireland’s Department of Health to help patients gain access to medical cannabis.

“We’re proud to have the opportunity to provide patients in Ireland with access to Tilray’s standardized GMP-certified medical cannabis products,” stated Catherine Jacobson the VP of Medical and Regulatory Affairs at Tilray.

Jacobson also noted that the development represents an important step forward not only for the company but also for medical marijuana patients in Ireland.  She also added that Tilray is pleased about the growing number of countries that are making an effort to boost access to medical marijuana.

Tilray is committed to making the cannabis products available to patients in Ireland

Qualified patients will get access to Tilray’s imported cannabis products via the Access Programme as soon as local regulators provide distribution approvals. This is also great news for qualified patients because it means they will access a consistent and legal supply of the products.  Additionally, the company aims to provide timely access to GMP-certified products, thus providing patients with even more convenience.

Authorized medical marijuana patients will access medical marijuana products from Tilray within the second half of 2019. The products will be made available through a network of Irish pharmacies. The company’s Managing Director for Europe, Sascha Mielcarek stated that the company was pleased about launching its products in Ireland. It is now the 13th country to import Tilray products for sale in its market.

Tilray also plans to continue expanding its operations in Europe and the rest of the world as part of its global expansion plan. These efforts plus the fact that more countries are embracing its products means that the company is gaining significant progress as and market share in its global endeavor.

By Steven Russell

Steve covers business and investing in emerging medical marijuana markets. Steve graduated from the university of New Orleans with a degree in Broadcast Journalism. Steve has published several articles in professional journals and magazines. His experience gives readers an inside look at the intersection of his specialties, business and medical marijuana.

Leave a Reply

Your email address will not be published. Required fields are marked *

Tilray Inc (NASDAQ:TLRY) Jupiter Research Provides A Production Update Despite The Emergence Of Coronavirus Tilray Inc (NASDAQ:TLRY) Lays Off A Fraction Of Its Workforce In Restructuring Efforts Tilray Inc (NASDAQ:TLRY) Witnesses A Mixed Business Performance Valens Groworks Corp (OTCMKTS:VGWCF) Agrees To Extract 60,000 Kg of Dried Cannabis Per Annum Under The Expanded Scope Of Agreement With Tilray Inc (NASDAQ:TLRY) Puration Inc (OTCMKTS:PURA) Gears Up to Reach $5 Million Sales Target in 2019 through Refreshing Deals

Pin It on Pinterest